VPIM
LAB icon

Vanguard Personalized Indexing Management’s Standard BioTools LAB Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.58K Sell
10,425
-6,200
-37% -$7.5K ﹤0.01% 2155
2025
Q4 		$21.3K Sell
16,625
-216
-1% -$290 ﹤0.01% 1936
2025
Q3 		$21.9K Buy
16,841
+1,155
+7% +$1.51K ﹤0.01% 1961
2025
Q2 		$18.8K Buy
+15,686
New +$17.4K ﹤0.01% 1910
2024
Q3 		– Sell
-11,033
Closed -$19.5K – 1801
2024
Q2 		$19.5K Buy
+11,033
New +$27K ﹤0.01% 1653

Other funds holding LAB

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HBWM
Hollow Brook Wealth Management Katonah, New York $392M AUM 36.68% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Vanguard Personalized Indexing Management's LAB Position: Q1 2026 in Review

Vanguard Personalized Indexing Management reduced its Standard BioTools (LAB) stake by 37% in Q1 2026, selling an estimated $7.5K and leaving 10,425 shares worth $9.58K. The position accounts for ﹤0.01% of the portfolio, ranked #2155.

Vanguard Personalized Indexing Management first reported a position in LAB in Q2 2024 and has held it in 5 quarters since. The position peaked at $21.9K in Q3 2025. 155 funds tracked by Wall St. Rank hold LAB as of Q1 2026.

  • Vanguard Personalized Indexing Management held 10,425 shares of Standard BioTools worth $9.58K as of Q1 2026.
  • Vanguard Personalized Indexing Management sold 6,200 Standard BioTools shares in Q1 2026, an estimated $7.5K.
  • Standard BioTools made up ﹤0.01% of Vanguard Personalized Indexing Management's portfolio in Q1 2026, its #2155 holding.
  • Vanguard Personalized Indexing Management first reported a position in Standard BioTools in Q2 2024 and has held it in 5 quarters since.
  • Vanguard Personalized Indexing Management's Standard BioTools position peaked at $21.9K in Q3 2025.
  • 155 funds tracked by Wall St. Rank held Standard BioTools as of Q1 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q1 2026, filed 14 May 2026.